Determining antibody-binding site of streptococcal pyrogenic exotoxin B to protect mice from group a streptococcus infection

PLoS One. 2013;8(1):e55028. doi: 10.1371/journal.pone.0055028. Epub 2013 Jan 31.

Abstract

Streptococcal pyrogenic exotoxin B (SPE B), a cysteine protease, is an important virulence factor in group A streptococcal (GAS) infection. SPE B binds and cleaves antibody isotypes and further impairs the immune system by inhibiting complement activation. In this study, we examined the antibody-binding site of SPE B and used it to block SPE B actions during GAS infection. We constructed different segments of the spe B gene and induced them to express different recombinant fragments of SPE B. Using an enzyme-linked immunosorbent assay (ELISA), we found that residues 345-398 of the C-terminal domain of SPE B (rSPE B(345-398)), but not the N-terminal domain, was the major binding site for antibody isotypes. Using a competitive ELISA, we also found that rSPE B(345-398) bound to the Fc portion of IgG. The in vitro functional assays indicate that rSPE B(345-398) not only interfered with cleavage of antibody isotypes but also interfered with SPE B-induced inhibition of complement activation. Immunization of BALB/c mice using rSPE B(345-398) was able to induce production of a high titer of anti-rSPE B(345-398) antibodies and efficiently protected mice from GAS-induced death. These findings suggest that SPE B uses its C-terminal domain to bind the Fc portion of IgG and that immunization of mice with this binding domain (rSPE B(345-398)) could protect mice from GAS infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Bacterial / blood
  • Antibodies, Bacterial / chemistry
  • Antibodies, Bacterial / immunology*
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / immunology*
  • Bacterial Proteins / pharmacology
  • Bacterial Vaccines / chemistry
  • Bacterial Vaccines / immunology
  • Bacterial Vaccines / pharmacology
  • Binding Sites
  • Complement Activation / drug effects
  • Complement Activation / immunology
  • Exotoxins / chemistry
  • Exotoxins / immunology*
  • Exotoxins / pharmacology
  • Humans
  • Immunization
  • Immunoglobulin Fc Fragments / immunology
  • Male
  • Mice
  • Protein Structure, Tertiary
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / immunology
  • Recombinant Proteins / pharmacology
  • Streptococcal Infections / prevention & control*
  • Streptococcus pyogenes / immunology
  • Streptococcus pyogenes / physiology*

Substances

  • Antibodies, Bacterial
  • Bacterial Proteins
  • Bacterial Vaccines
  • Exotoxins
  • Immunoglobulin Fc Fragments
  • Recombinant Proteins
  • erythrogenic toxin

Grants and funding

This work was supported by grants ISU101-04-02 from I-Shou University and NSC97-2320-B214-001-MY3, NSC100-2320-B-214-007 as well as NSC101-2320-B-214-004 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.